Ipamorelin + Tesamorelin

Ipamorelin + Tesamorelin

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

58

authors mention this stack

23

ran the components concurrently

Ipamorelin + Tesamorelin (Ipamorelin + Tesamorelin) appears in 58 author journeys (23 as actual concurrent use). Common goals: unclear; general peptide protocol; visceral fat reduction, avoiding excessive Ipamorelin intake associated with peptide blends. Typical doses reported: Ipamorelin 100mcg, Tesamorelin 2mg. Reported side effects include: not stated Research: 1 study discusses two or more of these components together (1 clinical); the components appear across 35 studies in total.

Research support

1 research study discusses two or more of these components together (1 clinical). Per-component literature:

Ipamorelin 7 studies (1 clinical)
Tesamorelin 29 studies (20 clinical)

PubMed/PMC articles mentioning each compound in title or abstract.

Typical doses reported

Ipamorelin 100mcg
Tesamorelin 2mg

Community-reported doses are not medical guidance.

How people are running it

21

Recommended / discussed

15

Planning to run

12

Currently running

11

Ran in the past

What people use it for

uncleargeneral peptide protocolvisceral fat reduction, avoiding excessive Ipamorelin intake associated with peptide blendsLibido enhancement (PT-141) and growth hormone stimulation/anti-aging (Tesamorelin/Ipamorelin)fat loss and increasing IGF-1 levelsburn belly fat

Sample reported outcomes

  • ✓ 5 days a week was very effective for the author
  • ✓ PT-141 injections successfully increased libido, unlike the sublingual alternative.
  • ✓ Unclear, planning trial and error with the premixed vials
  • ✓ Anecdotally suggested to significantly elevate growth hormone levels through synergy
  • ✓ Subtle but good results using normal recommended dosages
  • ✓ None reported yet
  • ✓ Adjusted doses downward to achieve desired blood test results and ranges.
  • ✓ Synergistic GH release, amplified peak amplitude of GH pulse, neutralized somatostatin, and downstream IGF-1 elevation without synthetic HGH side effects.

Self-reported community experiences, not verified results.

Sample reported side effects

  • ⚠ not stated
  • ⚠ PT-141 caused flushing (bright red face starting 20-30 mins post-injection and lasting an hour), diarrhea (the runs 1-2 hours post-injection), darkening of skin patches/birthmarks, and initial mild nausea.
  • ⚠ None reported
  • ⚠ High doses (e.g., 2mg Tesamorelin stacked with 300mcg Ipamorelin) are described as 'overwhelming' in intensity and side effects
  • ⚠ Solution thickening
  • ⚠ Initial water weight gain
  • ⚠ Stinging and itchiness at the injection site
  • ⚠ drenching night sweats